Category: GLP-1 RAs (Drug)

Costco to Sell Ozempic and Wegovy, Weight-Loss Wonder Drugs

Costco members will pay $499 a month out of pocket, the same price offered at CVS and Walmart, and on the manufacturer’s direct-to-consumer website.
How Private Equity Oversees the Ethics of Drug Research

Many drug trials are vetted by companies with ties to the drugmakers, raising concerns about conflicts of interest and patient safety.
Pill Causes Major Weight Loss in Eli Lilly Trial’s Results

The company said it planned to seek Food and Drug Administration approval for the drug, orforglipron, before the end of the year.
How Ozempic Maker Novo Nordisk Lost Its Shine

The pioneering Danish drugmaker was once the most valuable company in Europe, but analysts say a number of missteps reversed its fortunes.
Ozempic Maker’s Stock Plunges 20% After Profit Warning

Novo Nordisk slashed its financial forecasts as it struggled to fight off competition in the United States. It also named a new chief executive, who highlighted the “urgency” of the moment.
America’s Whey Protein Obsession Is Transforming the Dairy Industry

Whey, the liquid byproduct of cheese making, was once considered waste. Now it is a key ingredient in the protein powders that Ozempic users and weight lifters are downing in ever-greater amounts.
What Katie Sturino Wants You to Know About Her Body (and Yours, Too)

The influencer is still pushing brands to make bigger sizes and is publishing a new novel with a plus-size heroine. She is also losing weight, but that doesn’t mean she’s not “body neutral” anymore.
Novo Nordisk to Replace C.E.O. After Losing Edge in Weight-Loss Drugs

The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market has grown fiercer.
Nine Federally Funded Scientific Breakthroughs That Changed Everything

The U.S. is slashing funding for scientific research, after decades of deep investment. Here’s some of what those taxpayer dollars created.
Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed by insurance that disrupt treatments for patients.
How Ozempic is Shaping Weddings

Medications taken for weight loss are starting to impact wedding planning — and perhaps nothing more than the dress fitting.
With Khloud, Khloe Kardashian Will Release a Protein-Packed Popcorn

Social media has fueled a “proteinification” of snacks, and Khloé Kardashian is hopping on board with a line of enhanced popcorn.